Skip to main content

Advertisement

Table 1 Fasting Plasma Lipid and Hormone Levels

From: Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics

Fasting Values Control n = 9 Diabetics n = 6 Diabetics + ROSI n = 6 ANOVA
Age (years) 36.4 ± 2.9 54.3 ± 4.2** 54.3 ± 4.1** 0.002
BMI (kg/m2) 24.3 ± 3.0 32.2 ± 2.1** 33.2 ± 2.0** 0.007
Glucose (mmol/L) 5.3 ± 0.15 8.84 ± 0.80* 7.0 ± 0.59 0.003
Triglyceride (umol/L) 1098 ± 177 2148 ± 399** 2152 ± 535 NS
NEFA (umol/L) 513 ± 41 650 ± 99 568 ± 61 NS
Insulin (pmol/L) 70.5 ± 5.1 121.0 ± 28.6 86.7 ± 11.7 NS
  1. Fasting plasma glucose, triglyceride, NEFA and insulin levels are presented as mean ± SEM where * p < 0.05 and ** p < 0.01 compared to control analyzed by ANOVA with Bonferroni post hoc test, where NS = not significant.